Status:
UNKNOWN
Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Imperial College Healthcare NHS Trust
Chelsea and Westminster NHS Foundation Trust
Conditions:
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus Disease 2019 (COVID-19) has been widespread worldwide since December 2019. It is highly contagious, and severe cases can lead to acute respiratory distress or multiple organ failure. On 11...
Detailed Description
Coronavirus Disease 2019 (COVID-19) has been widespread worldwide since December 2019. It is highly contagious, and severe cases can lead to acute respiratory distress or multiple organ failure and ul...
Eligibility Criteria
Inclusion
- have ECGs, Chest x-ray and/or chest CT imaging (with or without contrast)
- positive laboratory Covid-19 virus nucleic acid test (RTPCR assay with throat swab samples) or clinical suspicion for Covid-19 infection
- be aged \>18 years
Exclusion
- Suboptimal ECGs, chest radiographs or CT studies for deep learning methods due to artefacts including severe
- motion artefacts which causes blurring of the contours of or significant artefacts due to metallic prosthesis which causes image degradation
- Time-interval between ECGs, chest CT and the RT-PCR assay was longer than 7 days
Key Trial Info
Start Date :
May 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04510441
Start Date
May 26 2020
End Date
May 1 2022
Last Update
August 30 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
London North West University Healthcare NHS Trust
London, United Kingdom, HA1 3UJ
2
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom, TW7 6AF
3
Imperial College London (Hammersmith campus)
London, United Kingdom, W12 0NN
4
St Mary's Hospital
London, United Kingdom, W2 1NY